Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Alessandro Maselli CEO | NYSE Exchange | US1488061029 ISIN |
United States Country | 16,900 Employees | - Last Dividend | - Last Split | 31 Jul 2014 IPO Date |
Catalent, Inc. is a global leader in delivering innovative solutions for drug development, biologic therapeutics, and consumer health products. With its foundation dating back to 1933, Catalent prides itself on its comprehensive expertise in advancing molecules, biologics, and consumer health products from early development to full-scale production. The company operates through two main segments: Biologics, and Pharma and Consumer Health, providing a broad spectrum of services worldwide. Catalent is committed to serving the pharmaceutical, biotechnology, consumer health, animal health, medical devices, and cosmetics industries. Headquartered in Somerset, New Jersey, Catalent stands as a pivotal partner for companies in various healthcare sectors, facilitating the pathway from laboratory to market.
Biologics Segment Services:
Pharma and Consumer Health Segment Services:
Additional Services and Solutions: